Skip to main content

Table 1 Patients’ characteristics, surgery, follow-up and mortality

From: One-year patency control and risk analysis of eSVS®-mesh-supported coronary saphenous vein grafts

Patients (n) exclusive 3 non-device related deaths

19

Gender (n; male)

16

Age (years; mean ± std; min.-max.)

70.4 ± 9.5 (51–81)

Body weight (kg; mean ± std)

80.1 ± 15.0

Bodymassindex (kg/m2; mean ± std)

28.2 ± 5.3

NYHA / CCS classification (n; %)

NYHA

CCS

I

13 (68.4 %)

2 (10.5 %)

II

4 (21.1 %)

10 (52.7 %)

III

2 (10.5 %)

5 (26.3 %)

IV

0

2 (10.5 %)

Left ventricular ejection fraction (%; mean ± std)

49 ± 11

CAD in 1° relative (n; %)

17 (89.5 %)

Arterial hypertension (n; %)

18 (94.7 %)

Diabetes (n; %; on insuline/oral antidiabetics/diet)

0 (0 %) / 2 (10.5 %)/6 (31.5 %)

Dyslipidemia (n; %)

16 (84.2 %) + 1 (5.3 %) unknown

Smoking (n; %; current/former/never)

2 (10.5 %)/13 (68.4 %)/4 (21.1 %)

Previous myocardial infarction (n; %)

13 (68.4 %) + 5 (26.3 %) no + 1 (5.3 %) unknown

Previous cerebrovascular event (n; %)

2 (10.5 %) (TIA only)

Previous CABG (n; %)

0 (0 %)

Revascularisation (n;%; OPCAB/ECC/MECC)

11 (57.9 %)/5 (26.3 %)/3 (15.8 %)

Extracorporeal circulation time (min; mean ± std)1)

113.9 ± 35.5 (n = 8)

Cross clamp time (min; mean ± std)1)

79.9 ± 25.3 (n = 8)

Days on intensive care unit (mean ± std)

2.3 ± 1.3

In-hospital days (mean ± std)

10.3 ± 4.7

Directly device-related complications (n)

0

MACCE (n; %)

1 (5.3 %) (Stroke with paraparesis, complete remission)

  1. NYHA: New York Heart Association, CCS: Canadian Cardiovascular Society, CAD: Coronary arterial disease, TIA: Transient ischemic attack, CABG: Coronary artery bypass grafting, OPCAB: Off-pump coronary artery bypass, ECC: Extracorporeal circulation, MECC: Minimal extracorporeal circulation, MACCE: Major adverse cardiac and cerebrovascular event, 1) including concomitant aortic valve replacement